AI Drug Discovery Startup Earendil Is Said to Consider Hong Kong IPO

Earendil Labs, a biotechnology startup that uses artificial intelligence for drug discovery, is considering listing in Hong Kong, according to people familiar with the matter.

Earendil is working with China International Capital Corp. and Morgan Stanley on a share sale that might raise as much as $500 million, the people said, asking not to be identified discussing information that isn’t public.